|Bid||37.00 x 1000|
|Ask||55.05 x 1000|
|Day's Range||54.63 - 55.68|
|52 Week Range||36.26 - 56.34|
|Beta (3Y Monthly)||1.40|
|PE Ratio (TTM)||343.94|
|Earnings Date||Oct 31, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||58.82|
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of June 28. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]
MORRISVILLE, N.C., Oct. 14, 2019 -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization.
MORRISVILLE, N.C., Oct. 14, 2019 -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company was.
If the dismal preliminary sales performance was not enough, then the news pertaining to QIAGEN's (QGEN) current CEO Peer M. Schatz's stepping down came as another huge blow.
This FDA designation is expected to bolster Medtronic's (MDT) Aortic, Peripheral & Venous line within the broader Cardiac and Vascular group.
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Medical technology companies are rising bullishly in 2019. The best-performing medical stocks tend to have high Composite Ratings, reflecting strong growth metrics vs. all other stocks.
Syneos Health® (SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the launch of Why We Resist: The Surprising Truths About Motivating Behavior Change. Authored by Syneos Health experts, Kathleen Starr, PhD, Managing Director of Behavioral Science, and Leigh Householder, Managing Director, Innovation, Syneos Health Communications, the book examines decades of research ranging from the latest experiments to proven truths that reveal why people resist healthcare change and how to move from resistance to action.
MORRISVILLE, N.C., Sept. 09, 2019 -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today will showcase Syneos Health.
Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: Syneos, Carlisle, United Technologies, Ares Capital and Principal Financial
In 2016 Alistair Macdonald was appointed CEO of Syneos Health, Inc. (NASDAQ:SYNH). First, this article will compare...
Syneos Health climbs Wednesday after the company says the SEC hadn't recommended any enforcement action following a recent investigation.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HMS Holdings (HMSY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.